What Researchers Did
Researchers conducted a literature review of 391 articles published between 1980 and 2021 to examine the mechanisms and efficacy of hyperbaric oxygen therapy (HBOT) for Alzheimer's disease (AD).
What They Found
After reviewing 391 full-text articles from 1980-2021, the researchers found evidence from both clinical and experimental studies supporting the use of hyperbaric oxygen therapy (HBOT) for Alzheimer's disease. The review advocates for HBOT as a treatment intervention for AD, exploring its molecular and physiological mechanisms.
What This Means for Canadian Patients
Canadian patients with Alzheimer's disease might consider discussing hyperbaric oxygen therapy (HBOT) with their healthcare providers as a potential alternative treatment option. However, further research is recommended to establish specific treatment protocols and long-term cognitive benefits.
Canadian Relevance
This review article does not have a direct Canadian connection.
Study Limitations
A limitation is that this review synthesizes existing literature without providing new primary data or establishing a definitive long-term treatment protocol for HBOT in AD.